Ignite Creation Date:
2025-12-24 @ 1:39 PM
Ignite Modification Date:
2026-02-02 @ 9:57 AM
Study NCT ID:
NCT06102395
Status:
RECRUITING
Last Update Posted:
2023-10-30
First Post:
2023-04-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC
Sponsor:
Beijing Tongren Hospital
Organization: